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Abstract
Background:  The diversity of genotyping markers of Plasmodium falciparum depends on
transmission intensity. It has been reported that the diversity of the merozoite surface protein 2
(msp2) is greater in areas of high compared to low endemicity, however, results for msp1 were
inconsistent. These previous reports relied on low resolution genotyping techniques.
Methods: In the present study, a high-resolution capillary electrophoresis-based technique was
applied to genotype samples from areas of different endemicity in Papua New Guinea and Tanzania.
For both endemic settings, the diversity of msp1 and msp2 was investigated; the mean multiplicity
of infection (MOI) and the FST values were determined to investigate whether more accurate sizing
generates different results.
Results and Conclusion: The results of the present study confirmed previous reports of a higher
mean MOI for both marker genes and increased genetic diversity in areas of higher endemicity as
estimated by the total number of distinct alleles for msp2. For msp1 a minor increase in diversity
was observed. Measures of between population variance in allele frequencies (FST) indicated little
genetic differentiation for both marker genes between the two populations from different endemic
settings. MOI adjusted for the probability of multiple infections sharing the same allele was
estimated by using the msp2 allele frequency distribution and the distribution of observed numbers
of concurrent infections. For the high-resolution typing technique applied in this study, this
adjustment made little difference to the estimated mean MOI compared to the observed mean
MOI.
Background
Plasmodium falciparum populations are highly diverse and
individual hosts are often simultaneously infected by
multiple parasite clones. In order to discriminate parasite
clones within one host PCR-based genotyping of a
number of different marker genes has been established.
Among these are the merozoite surface proteins 1 and 2
(msp1 and msp2) and the glutamate-rich protein (glurp),
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which show extensive length polymorphism and can,
therefore, be distinguished by electrophoresis on agarose
or polyacrylamide gels.
Recently, capillary electrophoresis (CE) based genotyping
of msp2 was shown to have a much higher discriminatory
power than previously applied techniques [1]. This tech-
nique has been proven useful in areas of high endemicity,
where individuals are simultaneously infected with many
different parasite clones. It has also been useful for distin-
guishing recrudescent from new infections after anti-
malarial treatment [2] and in tracking individual parasite
clones over time in longitudinal surveys, where consecu-
tive blood samples were collected from each individual
[1]. Similar to the CE based msp2 genotyping, a CE proto-
col for genotyping the polymorphic block 2 of the
msp1gene was applied in the present study.
The focus of this study was to assess the impact of trans-
mission intensity on the genetic diversity of the two
marker genes msp1 and msp2. Most previous studies have
shown a greater diversity for msp2 in high endemic set-
tings [3,4], but for msp1 conflicting results were reported
[5-12].
These data all relied on low-resolution genotyping con-
sisting of fragment sizing on agarose gels with individual
genotypes defined as bins of ≥ 20 base pairs. Using this
approach several distinct fragments may be combined
within one genotype bin. Greenhouse et al [13] studied
the impact of transmission intensity on the accuracy of
genotyping and found that with increasing transmission
intensity and, therefore, increasing complexity of infec-
tion, genotyping becomes less accurate. These findings are
not only important for recrudescent-reinfection typing in
anti-malarial drug trials, but also for assessing the impact
of transmission intensity on genetic diversity. The authors
concluded that a genotyping technique with higher dis-
criminatory power is needed for genotyping samples from
areas of high transmission intensity. In the study pre-
sented here an improved high-resolution genotyping
approach was applied to P. falciparum infected samples
from Papua New Guinea (PNG) and Tanzania (TZ). These
study sites differ extensively in their transmission inten-
sity with entomological inoculation rates of >300 infec-
tive bites per person per year reported for TZ [14,15] and
approximately 35 infective bites per person per year for
PNG [16]. The main question was to assess whether the
previously observed difference in msp1 and msp2 diversity
in different endemic settings is independent of technical
approaches or whether more sensitive detection of allelic
size differences would alter these previous results. For
direct standardized comparison the same genotyping
technique was applied for all samples.
Methods
The msp1 and msp2 loci were subject to high-resolution
genotyping in two sets of DNA samples that had been PCR
positive in previous tests. 108 samples from PNG were
derived from a longitudinal field survey in one- to four-
year old children, conducted in an area near Maprik, East
Sepik Province (Lin et al, personal communication). Sci-
entific approval and ethical clearance for the study was
obtained from the Medical Research and Advisory Com-
mittee (MRAC) of the Ministry of Health in PNG and
from the Ethikkommission beider Basel in Switzerland.
Informed consent was sought from all parents or guardi-
ans prior to recruitment of each child. 115 Tanzanian
samples were derived from the placebo group of a vaccine
efficacy trial conducted from 1993-1994 in children
below five years of age in the village Idete, which is located
in the Kilombero District of Morogoro Region, Tanzania
[17]. A genotyping study performed in these trial partici-
pants has been published previously [18], where the same
marker gene msp2, but a different typing technique had
been used. Both sets of samples derive from studies where
morbid episodes were closely followed and anti-malarial
treatment was readily available. In both sites, newly intro-
duced drugs were administered, without evidence for
existing drug resistance in these areas.
Prior to PCR amplification of the msp1 and msp2 target
sequence, DNA was extracted from cell pellets using
QIAamp® 96 DNA Blood Kits (Qiagen, Australia) accord-
ing to the manufacturer's instructions. Msp2 genotyping
was performed as previously described by Falk et al [1],
with some minor changes and adaptations of PCR condi-
tions for highly purified DNA. In brief, primary PCR reac-
tion conditions were adjusted to a final volume of 50 μl
including 2 μl of extracted DNA. Cycle conditions for pri-
mary PCR were 2 min at 94°C followed by 25 cycles of 30
s at 94°C, 45 s at 45°C, 90 s at 70°C, and a final extension
at 70°C for 10 min. In order to reduce the carry over of
primary PCR primers into the nested PCR, only one μl of
primary PCR product was amplified in the nested PCR
reaction with the following cycle conditions: 2 min at
94°C followed by 25 cycles of 30 s at 94°C, 45 s at 50°C,
90 s at 70°C and a final extension at 70°C for 10 min.
Msp1 occurs as one of three distinct allelic families: K1,
MAD20 and RO33. The unique family specific sequences
K1 and MAD20 flank intragenic repeat units that give rise
to extensive size polymorphisms, whereas RO33 is not
polymorphic. For amplification of the polymorphic
region of msp1 block 2 [19], a nested PCR approach was
used. Primary PCR was performed in a total volume of 50
μl containing 5 μl of 10 × BufferB (0.8 M Tris-HCl, 0.2 M
(NH4)2SO4, 0.2% w/v Tween-20), 2 mM MgCl2, 200 μM
dNTPs, 2.5 U Taq DNA polymerase (FirePol, Solis Bio-
Dyne). Primary PCR primers which are located in the con-Malaria Journal 2009, 8:250 http://www.malariajournal.com/content/8/1/250
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served sequence spanning the msp1 block2 (M1-OF 5'-
CTAGAAGCTTTAGAAGATGCAGTATTG-3' and M1-OR
5'-CTTAAATAGATTCTAATTCAAGTGGATCA-3' [20])
were used at a final concentration of 300 nM each. Two μl
of DNA was used as template for this PCR reaction. An ini-
tial denaturation step of 94°C for 2 min was followed by
30 amplification cycles of 30 s at 94°C, 1 min at 54°C, 1
min at 72°C and a final extension for 5 min at 72°C.
In the nested PCR reaction, specific primer pairs were used
to amplify the allelic families K1, MAD20 and RO33 of
msp1 block2. In order to distinguish the size of PCR prod-
ucts by capillary electrophoresis, one of the primers for
each PCR was labelled with the fluorescent dyes VIC, NED
or 6-FAM, respectively (Applied Biosystems). Size varia-
tions due to sporadic addition of adenine by the Taq
polymerase at the 3' end were avoided by adding a 7 bp
tail (Applied Biosystems) to the 5' end of the other primer
promoting the additional adenine incorporation. Primer
sequences for nPCR have previously been published [20],
but have been modified by fluorescent dyes and 7 bp tails:
M1-KF 5'-Tail-AAATGAAGAAGAAATTACTACAAAAG-
GTGC-3'; M1-KR 5'-NED-GCTTGCATCAGCTGGAG-
GGCTTGCACCAGA-3'; M1-MF 5'-Tail-
AAATGAAGGAACAAGTGGAACAGCTGTTAC-3'; M1-MR
5'-6-FAM-ATCTGAAGGATTTGTACGTCTTGAATTACC-3'.
K1 and MAD20 allelic sequences were amplified in a
duplex nPCR in a total volume of 50 μl, containing a final
primer concentration of 100 nM for each primer, 5 μl of
10 × BufferB (0.8 mM Tris-HCl, 0.2 M (NH4)2SO4, 0.2%
w/v Tween-29), 2 mM MgCl2, 200 μM dNTPs and 1.5 U
Taq DNA polymerase (FirePol, Solis BioDyne). 1 μl of pri-
mary PCR product was used as template for the nested
PCR with the following conditions: initial denaturation
for 2 min at 94°C followed by 35 cycles of 30 s at 94°C,
1 min at 59°C, 1 min at 72°C and a final extension for 10
min at 72°C. RO33 allelic sequences were amplified with
primers M1-RF 5' VIC-TAAAGGATGGAGCAAATACT-
CAAGTTGTTG-3' and the reverse primer M1-R2 5' Tail-
CAAGTAATTTTGAACTCTATGTTTTAAATCAGCGTA-3'
which is located in the conserved region of msp1 block3
and is not family specific. Therefore, RO33 nested PCR
was run as a separate reaction under the same conditions
as described for K1 and MAD20 nested PCR. All amplifi-
cations were performed on a PTC-100 thermocycler (MJ
Research Inc.).
Nested PCR products were analysed on a 1.5% agarose
gel. Depending on the intensity of the band, PCR products
were diluted 1:5 - 1:40 in H2O. 2.5 μl of diluted PCR prod-
uct was mixed with 0.3 μl GeneScan®-500 LIZ® size stand-
ard (Applied Biosystems) and 12 μl HiDi (highly
deionized) formamide. The mixture was heated for 5 min
at 95°C to separate the double strands and then immedi-
ately chilled on ice for a few minutes before capillary elec-
trophoresis was performed on an AB3130 Sequencer
(Applied Biosystems).
Data were analysed using the GeneMapper® v3.7 Software
(Applied Biosystems). The results of size calling were
exported as a tab delimited file and imported into an in-
house generated software, which calculated for each sam-
ple a cut-off based on the mean height of the size standard
peaks and grouped all alleles into 3 bp bins. For the cut-
off, an empirically defined constant factor was multiplied
by the mean size standard for each sample. This constant
factor was manually defined after inspecting the back-
ground level in single infections. For both marker genes
the total number of alleles as well as their frequency dis-
tributions were analysed. The theoretical probability of
being infected by two parasites with the same allele was
calculated as P = Σpi
2 where pi is the frequency of allele i
[21]. The combined probability that two independent
clones share the same genotype for both marker genes was
calculated by multiplying the probabilities P for both
marker genes, assuming that the two loci sort independ-
ently from each other. As a measure for genetic diversity,
the expected heterozygosity was calculated by use of the
formula HE = [n/(n-1)] × [(1-Σpi
2)] [22], where n is the
number of samples and pi the frequency of allele i. HE is
the probability that two alleles randomly drawn from the
population sample are different. The mean multiplicity of
infection (MOI) was calculated as the total number of
clones divided by the number of positive samples for each
marker gene. Allele frequencies were further compared
between populations from PNG and TZ using Wright's F
statistics to calculate the fixation index FST. FST is a measure
of between population variance and gives the proportion
of overall diversity which is attributable to differences
between populations [23]. HE and FST values were calcu-
lated by Arlequin ver3.1 software [24].
Estimates were calculated for both, the frequency distribu-
tion and the mean MOI adjusted for the probability of
multiple infections sharing the same allele using the msp2
allele frequency distribution and the distribution of
observed numbers of infections according to the method
of Ross et al (personal communication).
Results and discussion
The distribution of msp1 and msp2 allele frequencies for
108 Papua New Guinean samples is shown in Figure 1.
The total number of alleles detected in this sample set is
greater for msp2 than msp1, with 35 vs. 24 differently sized
alleles, respectively. The overall genetic diversity is also
slightly greater for msp2 than msp1 (P = 0.07; HE = 0.933
for msp2 and P = 0.084; HE = 0.918 for msp1). By combin-
ing the two marker genes, the probability that two parasite
clones share the same genotype by chance can be reduced
to 0.0058. Figure 2 shows the allelic frequency distribu-Malaria Journal 2009, 8:250 http://www.malariajournal.com/content/8/1/250
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Allelic frequencies of msp1 and msp2 in samples from Papua New Guinea Figure 1
Allelic frequencies of msp1 and msp2 in samples from Papua New Guinea. A. White, grey and black areas indicate 
frequencies of K1, MAD20 and RO33 alleles, respectively. B. White and grey areas indicate Fc27 and 3D7 allele frequencies, 
respectively.
Allelic frequencies of msp1 and msp2 in samples from Tanzania Figure 2
Allelic frequencies of msp1 and msp2 in samples from Tanzania. A. White, grey and black areas indicate frequencies of 
K1, MAD20 and RO33 alleles, respectively. B. White and grey areas indicate Fc27 and 3D7 allele frequencies, respectively.Malaria Journal 2009, 8:250 http://www.malariajournal.com/content/8/1/250
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tion of msp1 and msp2 in 115 samples from Tanzania. In
the Tanzanian samples, the total number of msp2 alleles
detected by CE was much greater than for msp1 with 76 vs.
29 alleles discriminated, respectively. The probability P of
being infected by two parasites with the same allele and
the expected heterozygosity values HE showed a greater
overall diversity for msp2 compared to msp1 (P = 0.036; HE
= 0.965 for msp2 and P = 0.085; HE = 0.917 for msp1) in
Tanzanian samples. Combining the two marker genes
reduced the probability that two parasites share the same
genotype by chance to 0.003.
In both countries, msp1 K1 type alleles were the most pol-
ymorphic, followed by MAD20 type alleles, whereas
RO33 was non-polymorphic. For msp2, alleles belonging
to the 3D7 family showed much more polymorphism
than Fc27 type alleles, in both countries (Table 1). For
msp1, the most dominant alleles were similar between
PNG and TZ. For msp2 the most frequent allele was the
same between the two sites whereas the remaining alleles
showed a different order of frequency. It is clear that meas-
uring length polymorphism only detects a fraction of
diversity in the marker genes. However, for genotyping
multiple infections, extensive length polymorphism is
ideal for discriminating individual infections. Sequencing
would require cloning individual PCR fragments. The var-
iance in allele frequencies between the two study sites was
compared using Wright's F statistics. The FST values for pair
wise comparisons of allele frequencies between popula-
tion samples were 0.041 for msp1 and 0.017 for msp2,
respectively (p < 0.001 for both markers). These low FST
values indicate that allele frequencies are highly similar
and that there is little genetic differentiation between the
investigated geographic populations for both marker
genes. As previously suggested, such low FST values may
indicate that the msp1 and msp2 loci are under balancing
selection [25], increasing the possibility that observed pat-
terns of allele frequencies are the result of balancing selec-
tion rather than of variation in transmission dynamics.
The quality of genotyping, i.e. optimal differentiation of
parasite clones within a blood sample and between sam-
ples depends on a number of parameters. It is essential
that the chosen marker gene is highly polymorphic. Many
genotyping applications require minimization of the
probability that two parasites share the same allele by
chance. Minimizing this probability is achieved by choos-
ing the most polymorphic marker, but also the allelic fre-
quency distribution plays a crucial role and should be
homogeneous. The more homogeneous the distribution
of alleles, the more diversity the marker will have [21].
Discrimination can be enhanced by using a second
marker gene, which further reduces the probability that
two clones share the same genotype by chance. In fact, the
number of marker genes that should be used to ade-
quately discriminate parasites can be different between
study sites and it has been recommended to choose the
number of genes in a way that this probability is below
0.05 [21]. The study presented here has shown that in
Tanzania, the msp2 gene is highly diverse with a total of 76
differently sized alleles, and that the probability P of being
infected with two parasites sharing the same msp2 geno-
type is only 3.6%. In contrast, the frequency distribution
of the msp1 gene in Tanzania is less favourable, since only
29 alleles could be distinguished and the most common
allele has a frequency of >20%. These results suggest that
in a high transmission region in Tanzania, where this
study was conducted, CE genotyping for msp2 alone pro-
vided sufficient discrimination power to adequately dif-
ferentiate parasites, since the probability P that two
parasites share the same genotype was 3.6%. For msp1
however, the genetic diversity was not sufficient for use as
a single genotyping marker. The number of alleles was
greater for both marker genes in Tanzanian samples than
in samples from Papua New Guinea (msp1: 24 vs. 29;
msp2: 35 vs. 76 in PNG vs. TZ, respectively, Table 2).
Although the overall genetic diversity in PNG was slightly
greater for msp2 than for msp1 with 35 vs. 24 alleles, the
diversity of msp2 in this area was not high enough for msp2
to be used as a single marker for genotyping. This is due to
a high probability (7%) of being infected with two para-
sites sharing the same allele by chance, which is above the
5% threshold suggested by Gatton & Cheng [21]. There-
Table 1: Number of different msp1 and msp2 alleles detected in samples from Papua New Guinea and Tanzania
Papua New Guinea Tanzania
Number of different msp1-K1 alleles 13 19
Number of different msp1-MAD20 alleles 10 9
Number of different msp1-RO33 alleles 1 1
Number of different msp2-3D7 alleles 27 59
Number of different msp2-Fc27 alleles 8 17Malaria Journal 2009, 8:250 http://www.malariajournal.com/content/8/1/250
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fore, genotyping of both msp2 and msp1 is required in
order to increase discriminatory power in this area. Com-
bining the two marker genes reduced the probability that
two parasites share the same genotype by chance to 0.6%.
In an area of lower transmission, genotyping two or more
markers is clearly an option for single clone infections as
msp1-msp2 haplotypes are evident. In the case of frequent
multiple clone infections, this strategy is less beneficial as
both markers are unlinked and msp1-msp2  haplotypes
cannot be determined. This shortfall poses a serious hand-
icap if an individual parasite clone needs to be followed
up over time in a longitudinal series of samples. Other
applications, e.g. identification of new infections, are well
suited for combining several markers.
Mean MOI was significantly greater in Tanzania than in
PNG for both marker genes (msp1: 1.99 vs. 3.04; p < 0.001
and msp2: 1.84 vs. 3.72, p < 0.001 for PNG vs. TZ, respec-
tively, Table 2), which confirms previous observations of
an increased complexity of infection with increasing ende-
micity [3,26]. In Tanzanian samples, the mean MOI was
significantly greater for msp2 than for msp1 (p < 0.001),
which reflects the great difference in the number of dis-
tinct alleles between the two allelic families. Despite the
fact that the number of alleles was also greater for msp2
than for msp1 in PNG, the mean multiplicity of infection
was slightly higher for msp1, however, this difference was
not statistically significant. This minor difference in mean
MOI might be due to various technical reasons like differ-
ences in PCR efficiency for the two marker genes, which
results in different detection limits. Another parameter
that influences the number of genotypes per sample is the
cut-off that is determined for each sample, which is
dependent on the internal size standard used to control
for unequal loading of the PCR product onto the auto-
mated sequencer. The use of two markers obviously pro-
duces minor discrepancies due to technical differences,
but does not affect the overall MOI result.
Because MOI was considerably higher in samples from TZ
than in those from PNG, the total number of clones used
for assessing diversity differed between the two data sets.
This could have biased the results in that the diversity in
PNG would be under-estimated by observing fewer
clones. Therefore, the analysis of the msp2 diversity was
repeated with a two-fold increased number of samples
from PNG, so that the total number of clones was approx-
imately equal in both data sets (data shown in additional
files 1 and 2). A minor increase in the number of distinct
alleles was observed, with four newly observed alleles
occurring only 1-3 times. Thus, comparing approximately
400 clones from each site did not yield a different estimate
of diversity as opposed to comparing approximately 100
blood samples form each site. The expected heterozygos-
ity HE and the probability P that two parasites share the
same allele by chance remained similar.
The results obtained by applying this high-resolution gen-
otyping technique revealed similar results to previous
reports on allelic diversities in three areas of different
Table 2: Diversity of msp1 and msp2 in samples from Papua New Guinea and Tanzania
Papua New Guinea Tanzania
msp2 msp1 msp2 msp1
Number of samples (n) 108 108 115 115
Number of alleles 35 24 76 29
Frequency of most common allele 15.08% 16.28% 11.21% 20.57%
Number of clones 199 215 428 350
Mean MOI* 1.84 1.99 3.72§ 3.04§
HE** 0.933 0.918 0.965 0.917
P = Σpi
2 0.07 0.084 0.036 0.085
Combined probability*** 0.0058 0.003
* MOI = mean multiplicity of infection
** HE = expected heterozygosity. This is defined as the probability that two randomly chosen alleles are different in the population.
*** The combined probability that two independent clones share the same genotype for both marker genes was calculated by multiplying the 
probabilities P for both marker genes.
§ Indicates significant difference between mean MOI of msp1 and msp2 (p < 0.001)Malaria Journal 2009, 8:250 http://www.malariajournal.com/content/8/1/250
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malaria endemicity in Brazil, Vietnam and Tanzania,
where the extent of allelic diversity of msp2 as estimated
by the total number of distinct alleles increased with
increasing endemicity [4]. The same populations were
also investigated for genetic diversity in the msp1 gene. In
contrast to msp2, the extent of msp1 diversity did not seem
to correlate with the level of malaria transmission in these
regions [5-9]. The present observations of only a minor
effect of transmission intensity on diversity of msp1 con-
firmed these previous findings. An increased diversity of
msp2 in areas of higher endemicity was also reported pre-
viously [3,10,11,27], however, most of these studies also
reported a correlation between endemicity and the
number of distinct alleles for msp1, which was not the case
for the comparison of diversity between Brazil, Vietnam
and Tanzania and in the present study. There were also
some studies that did not find a correlation between trans-
mission intensity and genetic diversity for both marker
genes [12,28,29].
The findings presented here might have implications for
genotyping samples from drug efficacy trials where recru-
descence must be reliably distinguished from new infec-
tions and the probability of new infecting parasites having
the same allele as the initial infecting parasite should be
as low as possible. The data presented here suggest that for
this purpose msp2 is the more suitable marker gene than
msp1 in both study sites. Genotyping only msp1 would not
provide adequate discriminatory power according to the
standards suggested by Gatton and Cheng [21] as the
probability of being reinfected with the same genotype is
8.5%. In areas of lower transmission intensity, such as in
PNG, genotyping only one marker gene (either msp1 or
msp2) will not provide enough discriminatory power and
two markers are necessary to improve discrimination
power. In highly endemic areas like Tanzania, the resolu-
tion obtained with msp2 might be sufficient to discrimi-
nate all concurrent clones within an individual, as the
probability of multiple parasites sharing the same allele is
low. However, the high mean MOI in this area is likely to
lower the discriminatory power. This effect of high MOI
on the resolution of genotyping markers has so far been
given little attention [13] in genotyping studies. It is of rel-
evance in particular for genotyping of recrudescences in
highly endemic areas, because high MOI increases the
probability of super-infected parasite clones to carry the
same genotype. Therefore an attempt was made to esti-
mate the true number of alleles present in a host, allowing
for this probability. Details of the estimation approach are
being published elsewhere (Ross et al, personal communi-
cation). Table 3 lists the probability of observed infections
conditional on the true number of infections based on the
PNG allelic frequencies. Adjustment for the probability of
multiple infections sharing the same msp2 allele made lit-
tle difference to the estimated MOI (estimated mean MOI
was 1.84 in PNG, 3.99 in Tanzania compared to the unad-
justed values of 1.84 in PNG and 3.72 in TZ, respectively).
This reflects the low probability of being infected with two
parasites sharing the same allele with such a high-resolu-
tion typing system.
Conclusion
In conclusion, the CE-based genotyping, which provides
highly accurate fragment sizing data, is in line with previ-
ous findings on genetic diversity in different geographic
locations. A higher mean MOI for both marker genes was
found in an area of more intense malaria transmission.
Msp2 diversity was higher in the high transmission area,
but msp1 only showed a minor increase in diversity. The
between population variance in allele frequencies, as esti-
mated by Wright's F statistics, was found to be very low for
both marker genes. This indicates that there was little
genetic differentiation between the two sites of different
endemicity and suggests that the observed patterns of
allele frequencies are independent of transmission inten-
sity.
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